Showing results (11-20 of 125) with videos related to
Sort By:
Pageof 13
Acta Medica Scandinavica|October 1, 1975
Predictable reduction in anticoagulant activity of warfarin by small amounts of vitamin KP Andersen, H C GodalThrombosis Research|August 15, 1985
Evidence that changes in fibrinogen quality during acute phase reactions are of major importance for the amount of heparin precipitable fraction (HPF)B Holm, H C GodalTidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|January 7, 1998
[Measurement of health-related quality of life in malignant diseases. Does it have any consequences?]F WisløffScandinavian Journal of Clinical and Laboratory Investigation|October 1, 1976
Impaired anticoagulant effect of heparin in the artificial kidney. An experimental studyJ Björnson, H C GodalHaemostasis|January 1, 1977
The antiheparin effect of alpha1-acid glycoprotein and platelet material, evaluated by the heparin thrombin clotting timeP Andersen, H C GodalScandinavian Journal of Haematology|January 1, 1984
Evidence that fibrin(ogen) degradation products (FDP) are adequately quantified in citrated plasma defibrinated at low pHH C Godal, T HamborgHaemostasis|January 1, 1977
Qualitative changes in fibrinogen following exposure to agents used for preparation of fibrin monomersF Brosstad, H C GodalThrombosis Research|August 1, 1984
Quantitation of the three normally-occurring plasma fibrinogens in health and during so-called "acute phase" by SDS electrophoresis of fibrin obtained from EDTA-plasmaB Holm, H C GodalScandinavian Journal of Haematology|November 1, 1977
An inhibitor of activated factor XIII, inhibiting fibrin cross-linking but not incorporation of amine into caseinH C Godal, B LyScandinavian Journal of Haematology|January 1, 1979
Haemolysis in athletes due to hereditary spherocytosisH C Godal, H E RefsumPageof 13